H. Sun, S.G. DiMagno / Journal of Fluorine Chemistry 128 (2007) 806–812
[2] Y.-S. Ding, J.S. Fowler, Drug Dev. Res. 59 (2003) 227–239.
811
obtained from Fluka Chemical Co. and dried under vacuum at
40 8C overnight prior to use. TBAF* was prepared from
TBACN as was described previously [40]. Tetramethylammo-
nium hexafluorophosphate (TMAPF6) was obtained from Fluka
and dried under vacuum. All other reagents were of analytical
grade, from Aldrich Chemical Company. 1H, 13C and 19F NMR
spectra were collected and analyzed in the Instrumentation
Center at the University of Nebraska-Lincoln. 400 MHz (QNP
probe) and 600 MHz (HF probe) NMR spectrometers were
used in this study.
[3] J.S. Fowler, N.D. Volkow, G.-J. Wang, Y.-S. Ding, S.L. Dewey, J. Nucl.
Med. 40 (1999) 1154–1163.
[4] M.-C. Lasne, C. Perrio, J. Rouden, L. Barre, D. Roeda, F. Dolle, C.
Crouzel, Top. Curr. Chem. 222 (2002) 201–258.
[5] R. Weissleder, Science 312 (2006) 1168–1171.
[6] T. Irie, K. Fukushi, T. Ido, Int. J. Appl. Rad. Isotopes 33 (1982) 445–448.
[7] T. Irie, K. Fukushi, O. Inoue, T. Yamasaki, T. Ido, T. Nozaki, Int. J. Appl.
Rad. Isotopes 33 (1982) 633–636.
[8] G. Angelini, M. Speranza, A.P. Wolf, C.Y. Shiue, J. Fluorine Chem. 27
(1985) 177–191.
[9] C.Y. Shiue, J.S. Fowler, A.P. Wolf, D.W. McPherson, C.D. Arnett, L.
Zecca, J. Nucl. Med. 27 (1986) 226–234.
[10] M.S. Haka, M.R. Kilbourn, G.L. Watkins, S.A. Toorongian, J. Labell.
Compd. Radiopharm. 27 (1989) 823–833.
4.2. Computational studies
[11] T.J. McCarthy, A.U. Sheriff, M.J. Graneto, J.J. Talley, M.J. Welch, J. Nucl.
Med. 43 (2002) 117–124.
All calculations were performed on a 128 node computer
(Prairie Fire) at the University of Nebraska-Lincoln computing
facility. The Gaussian-view 03W interface and Gaussian-03
programs were used for the calculations.
[12] S. Oya, S.R. Choi, H. Coenen, H.F. Kung, J. Med. Chem. 45 (2002) 4716–
4723.
[13] A.A. Wilson, R.F. Dannals, H.T. Ravert, M.S. Sonders, E. Weber, H.N.
Wagner Jr., J. Med. Chem. 34 (1991) 1867–1870.
[14] Y. Seimbille, M.E. Phelps, J. Czernin, D.H.S. Silverman, J. Labell.
Compd. Radiopharm. 48 (2005) 829–843.
4.3. Syntheses of trimethylanilinium triflate salts [20]
[15] G. Getvoldsen, A. Fredriksson, N. Elander, S. Stone-Elander, J. Labell.
Compd. Radiopharm. 47 (2004) 139–145.
To
a
solution of para-substituted dimethylaniline
[16] B. Kuhnast, S. Klussmann, F. Hinnen, R. Boisgard, B. Rousseau, J.P.
Fuerste, B. Tavitian, F. Dolle, J. Labell. Compd. Radiopharm. 46 (2003)
1205–1219.
(4.0 mmol) dissolved in dry benzene (10 mL) was added
methyl triflate (0.63 mL) at room temperature. The reaction
mixture was stirred at room temperature to 40 8C for 30 min to
8 h. At the conclusion of the reaction the trimethylanilinium
triflate salt precipitated from solution. The precipitate was
isolated by filtration, washed with dry benzene (5ꢃ 5 mL), and
residual solvent was removed in vacuo. Excellent yields (>80%
isolated) were obtained for all of the methylation reactions.
These previously reported compounds were characterized by
1H, 19F, and 13C NMR spectroscopy.
[17] B. Kuhnast, F. Hinnen, R. Boisgard, B. Tavitian, F. Dolle, J. Labell.
Compd. Radiopharm. 46 (2003) 1093–1103.
[18] E.F.J. de Vries, J. Vroegh, P.H. Elsinga, W. Vaalburg, Appl. Radiat.
Isotopes 58 (2003) 469–476.
[19] B. Kuhnast, F. Dolle, B. Tavitian, J. Labell. Compd. Radiopharm. 45
(2002) 1–11.
[20] B. Kuehnast, F. Dolle, S. Terrazzino, B. Rousseau, C. Loc’h, F. Vaufrey, F.
Hinnen, I. Doignon, F. Pillon, C. David, C. Crouzel, B. Tavitian, Bioconj.
Chem. 11 (2000) 627–636.
[21] B. Kuhnast, F. Dolle, F. Vaufrey, F. Hinnen, C. Crouzel, B. Tavitian, J.
Labell. Compd. Radiopharm. 43 (2000) 837–848.
4.4. Reaction of TBAF* with trimethylanilinium triflate
salts
[22] T. Haradahira, Y. Hasegawa, K. Furuta, M. Suzuki, Y. Watanabe, K.
Suzuki, Appl. Radiat. Isotopes 49 (1998) 1551–1556.
[23] F. Dolle, F. Hinnen, F. Vaufrey, B. Tavitian, C. Crouzel, J. Labell. Compd.
Radiopharm. 39 (1997) 319–329.
To a solution of the appropriate trimethylanilinium triflate
salt (0.2 mmol in 0.3 mL of d6-DMSO) was added a solution of
TBAF* (0.26 mmol) in 0.2 mL d6-DMSO. The resulting
solution was mixed well and transferred into an NMR tube
equipped with a Teflon screw cap closure. The NMR tube was
placed into a preheated (100 8C) oil bath for the time indicated
in Table 1. The mixture was cooled by immersing the tube in a
cold water bath before the solution was assayed by 1H, 19F, and
13C NMR spectroscopy. The identities of all products were
confirmed by comparison of the spectra to those of authentic
samples.
[24] T. Toyokuni, J.C. Walsh, A. Dominguez, M.E. Phelps, J.R. Barrio, S.S.
Gambhir, N. Satyamurthy, Bioconjug. Chem. 14 (2003) 1253–1259.
[25] T. Poethko, M. Schottelius, G. Thumshirn, U. Hersel, M. Herz, G.
Henriksen, H. Kessler, M. Schwaiger, H.-J. Wester, J. Nucl. Med. 45
(2004) 892–902.
[26] H.T. Ravert, I. Madar, R.F. Dannals, J. Labell. Compd. Radiopharm. 47
(2004) 469–476.
[27] R.R. Kavali, B.C. Lee, B.S. Moon, S.D. Yang, K.S. Chun, C.W. Choi, C.-
H. Lee, D.Y. Chi, J. Labell. Compd. Radiopharm. 48 (2005) 749–758.
[28] E.D. Hostetler, S.D. Jonson, M.J. Welch, J.A. Katzenellenbogen, J. Org.
Chem. 64 (1999) 178–185.
[29] J. Ermert, K. Hamacher, H.H. Coenen, J. Labell. Compd. Radiopharm. 43
(2000) 1345–1363.
[30] Z. Li, Y.-S. Ding, A. Gifford, J.S. Fowler, J.S. Gatley, Bioconjug. Chem.
14 (2003) 287–294.
Acknowledgments
[31] W.R. Banks, R.D. Borchert, D.R. Hwang, Appl. Radiat. Isotopes 45 (1994)
75–81.
We thank the Nebraska Research Initiative for financial
support. This research was performed in facilities renovated with
funds from the National Institutes of Health (RR16544-01).
[32] W.R. Banks, D.R. Hwang, Appl. Radiat. Isotopes 45 (1994) 599–608.
[33] L. Lang, E. Jagoda, B. Schmall, B.-K. Vuong, H.R. Adams, D.L. Nelson,
R.E. Carson, W.C. Eckelman, J. Med. Chem. 42 (1999) 1576–1586.
[34] A.R. Jalilian, S.A. Tabatabai, A. Shafiee, H. Afarideh, R. Najafi, M.
Bineshmarvasti, J. Labell. Compd. Radiopharm. 43 (2000) 545–555.
[35] K.J. Guenther, S. Yoganathan, R. Garofalo, T. Kawabata, T. Strack, R.
Labiris, M. Dolovich, R. Chirakal, J.F. Valliant, J. Med. Chem. 49 (2006)
1466–1474.
References
[1] M.R. Kilbourn, Fluorine-18 Labeling of Radiopharmaceuticals, National
Academy Press, 1990.